(Q36612227)

English

Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation

scientific article published on August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

author name string

N Voorzanger-Rousselot

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

F Juillet

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

E Mareau

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Zimmermann

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

T Kalebic

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

P Garnero

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 August 2006

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

95

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

506-514

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603285

0 references

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Mechanisms of cancer metastasis to the bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

The OPG/RANKL/RANK system in metabolic bone diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Clinical review 165: Markers of bone remodeling in metastatic bone disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Fundamental Concepts of the Angiogenic Process

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Biochemical markers and skeletal metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Matrix metalloproteinases and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Cancer and bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Progelatinase A activation during tumor cell invasion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

30 September 2017

Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

28 June 2018

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

28 June 2018

Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

28 June 2018

Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

28 June 2018

Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

28 June 2018

Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

20 September 2018

A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

20 September 2018

Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

20 September 2018

The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

20 September 2018

Serum osteoprotegerin levels are increased in patients with advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

20 September 2018

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

20 September 2018

p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360666

20 September 2018

The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastasis gets site specific

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markers of bone turnover do not predict bone metastases in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of transforming growth factor beta1 in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum osteoprotegerin levels in healthy controls and cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basement Membrane Collagen: Degradation by Migrating Endothelial Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6603285

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36612227&oldid=1959813603"